Company Metrics
LIXT Bitcoin Exposure
LIXT Valuation Metrics
LIXT Stock Returns
LIXT Trading & Risk
LIXT Options
About LIXTE Biotechnology's Bitcoin Treasury Strategy
LIXTE Biotechnology (LIXT) ranks #160 globally among Bitcoin treasury companies, with 10.5 Bitcoin in its corporate treasury worth approximately $822.84K at current prices. This represents 0.000% of the total 21 million Bitcoin that will ever exist.
Trading at a stock price of $3.37 per share with a market capitalization of $39.15M, LIXTE Biotechnology's stock currently trades at an mNAV (enterprise value to Bitcoin NAV multiple) of 42.63x. Bitcoin holdings represent 2% of the company's market cap, underscoring Bitcoin's central role in LIXTE Biotechnology's balance sheet strategy.
Recent stock performance shows -9.16% over the past week, +9.77% over the past month, -14.25% year-to-date, and +167.46% over the past year. LIXTE Biotechnology currently trades -46.17% from its 52-week high. The stock averages $114.47K in daily trading volume over the past 30 days, with 30-day volatility at 76.3%.